Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetesTsuyoshi Mashitani, Hitoshi Yoshiji, Ryuichi Noguchi et al.|Biomedical Reports|2016Cited by 43
Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort StudySadanori Okada, Mio Sakuma, Hirofumi Soejima et al.|PLoS ONE|2016Cited by 31